Merck Advanced Technologies Co.,Ltd. operates as science and technology company. The company's product portfolio is made up of three business units: Healthcare business unit, Life Sciences Business unit, and Functional Materials Business unit. Healthcare business unit provides biopharma including pharmaceuticals that treats colorectal cancer, head and neck cancer, multiple sclerosis, obesity, growth hormone disease, cardiovascular disease, diabetes and thyroid disease ( hyperthyroidism, hypothyroidism, etc. Furthermore, Healthcare business unit is divided into three segments: General Pharmaceuticals provides OTC products such as pain reliever, cold and headache medicine and also provides dietary supplements of probiotic like vitamin C, vitamins, minerals and nutrients; Allergo Pharma portfolio consists of diagnostic products and treatments used in antigen immunotherapy (AIT); and Biosimilars is engaged in developing biosimilars for the treatment of tumors and inflammatory diseases. Life Sciences Business unit is used in laboratory research and development activities as well as in the discovery, development and manufacturing of synthetic and biopharmaceuticals. Functional Materials Business unit is made up of specialty chemicals and functional ingredients for the coatings, plastics, cosmetics, and food industries as well as consumer electronics, lighting, solar and printing technologies. Merck Advanced Technologies Co., Ltd was incorporated in 2002 and is based in Pyeongtaek , South Korea.
1173-2, Wonjeong-ri Poseung-eup Pyeongtaek-si Gyeonggi
Contact Details: Purchase the Merck Advanced Technologies Co.,Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service